![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 28, 2017 3:40:21 PM
CEO preplanned his sale back in August. He had no knowledge of the price or whether Senhace will get FDA approval.
Both of them put their own money last year. Bought at almost $2 per share. Just look at Nasdaq or Form4 in SEC. They sold only shares they purchased with their own money.
CEO and CFO still have more than 2 million share exposure.
Look at their compensation structure. They get paid almost 60% in stock and stock options. They have not sold those stocks yet.
SOFAR has not sold their shares, in fact increased. Aisling Capital, very very VERY close to TRXC. They have increased their position from 10 to 11mln shares as well.
Few sales of insider sales always happen. If they have cashed out entire or majority of their shares I would agree with you. However, there is nothing to read into here other than they invested personal capital and got them back out after major milestone was hit. Senhance approval by FDA. Anyway, in December there are 2 catalysts: EU sale announcement and 3mm instrument sales in EU.
Bears that are running naked will burn badly. Talk to you then!
Recent ASXC News
- Kuehn Law Encourages ICCH, DO, ASXC, and DPSI Investors to Contact Law Firm • PR Newswire (US) • 06/11/2024 12:04:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/07/2024 08:19:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/07/2024 12:50:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:50:23 PM
- Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ • GlobeNewswire Inc. • 06/07/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:33:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 10:55:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:51:25 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024 • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 10:55:00 AM
- Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 04/29/2024 10:55:00 AM
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG • GlobeNewswire Inc. • 04/03/2024 12:45:00 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 10:55:00 AM
- Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference • GlobeNewswire Inc. • 02/28/2024 11:55:00 AM
- Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals • GlobeNewswire Inc. • 02/27/2024 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:01:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:00:04 AM
- Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 01/16/2024 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:55:21 AM
- Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update • GlobeNewswire Inc. • 01/08/2024 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:45:21 PM
- Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System • GlobeNewswire Inc. • 01/04/2024 09:15:00 PM
- Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 11:55:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM